DIN 02530406 — RYLAZE 10 MG
RYLAZE is a solution of Crisantaspase marketed by JAZZ PHARMACEUTICALS IRELAND LIMITED. The full Crisantaspase monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02530406
- Brand name
- RYLAZE
- Active ingredient
- Crisantaspase
- Strength
- 10 MG
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR
- Manufacturer
- JAZZ PHARMACEUTICALS IRELAND LIMITED
- Health Canada status
- MARKETED
- Drug class
- Antineoplastic enzyme (asparaginase)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.